Skip to main content

Featured

Europe Grinds to a Halt as Deep Freeze Triggers Massive Travel Disruptions

                                                   KLM scraps 600 flights in Amsterdam on Wednesday as snow continues A powerful cold snap sweeping across Europe has forced widespread cancellations of flights and trains, with conditions expected to worsen through Wednesday. Heavy snowfall, freezing temperatures, and hazardous travel conditions have already caused days of disruption across the continent, and authorities warn that the situation may deteriorate further. Severe Weather Shuts Down Air Travel Dutch carrier KLM announced it will cancel 600 flights at Amsterdam Schiphol Airport on Wednesday as it struggles with persistent snow and freezing conditions. Schiphol, one of Europe’s busiest hubs, has been heavily affected since Friday, with thousands of flights disrupted and de‑icing operations running around the clock. Officia...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment